Injective price prediction: Further losses likely? Injective drops 8% on bearish momentum

Traders Union
All News
Crypto News
Injective slides 8.04% today

Highlights

INJ trades at $4.92, well below the MA-20 ($5.63), MA-50 ($6.42), and MA-200 ($10.92), confirming sustained bearish momentum across all timeframes.
Despite oversold readings on the RSI (34.56), Stochastic RSI, and CCI, intraday momentum remains negative with today's price down 8.04%, closing near the session low at $4.85–$4.97.
The five-day forecast expects INJ to range between $4.30–$5.10, with more than 80% probability of further downside and resistance at $5.80 unlikely to be breached.

Ongoing intraday weakness as oversold signals clash with selling pressure

Momentum remains firmly negative, as both the MACD and ADX indicate a clear sell environment. Oversold signals are present on the RSI (34.56), Stochastic RSI, and CCI, reinforcing downside exhaustion, but BBP and the Awesome Oscillator both confirm that sellers continue to dominate intraday momentum. Today, the price dropped 8.04% from the previous session, with no visible gap between the previous close and today’s open, and is currently near the session low within the $4.85–$4.97 range. Volatility is elevated, with clear pressure after the open supporting continued weakness; however, with the presence of multiple oversold oscillator readings, there is a mild divergence between persistent momentum and potential for a short-term relief bounce.

High probability of extended losses amid consolidation scenario

For the next five trading days, the expected range is $4.30–$5.10, reflecting the need to keep the forecast band within 20% of the current price due to the sharp decline. The probability of a further price decrease is very high (more than 80%), making a rebound much less likely. In the baseline scenario, the price may stabilize and consolidate sideways within the adjusted range after the recent sell-off. A bullish scenario would require a break above $5.80 (dynamic resistance), which is unlikely given negative momentum. Conversely, a bearish scenario could unfold if the price drops below $4.30, opening the way for further losses as downward momentum persists.

Viktoras Karapetjanc, market analyst at Traders Union, sees downside pressures in Injective (INJ) but notes that momentum exhaustion is building. He observes that the sharp decline and multiple oversold signals could spark a short-term bounce, even as bearish sentiment remains strong. The analyst emphasizes that without any positive news or structural shift, risks stay to the downside for now. In his view, short-term consolidation is possible before a more decisive move emerges. "I believe any meaningful recovery in INJ will need clear improvement in macro sentiment and an initial break above $5.80 before bulls can regain control."

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.